CJC-1295 with DAC (Driada Medical)

CJC-1295 with DAC (Driada Medical)

CJC-1295 with DAC by Driada Medical is a powerful, tetrasubstituted 30-amino acid peptide that functions as a long-acting analogue of Growth Hormone Releasing Hormone (GHRH).¹ The integration of the Drug Affinity Complex (DAC) is a critical modification that binds the peptide to albumin in the blood, significantly extending its half-life.

This advanced delivery system ensures that a single dose can maintain elevated levels of both Growth Hormone (GH) and Insulin-like Growth Factor 1 (IGF-1) for several days, providing a more efficient solution compared to traditional short-acting peptides.

Technical Product Specifications

Core Benefits and Research Profile

CJC-1295 DAC is highly regarded in regenerative and performance research for its sustained physiological impact:

• Extended Half-Life: The DAC technology allows for a steady release of Growth Hormone, eliminating the necessity for daily administration.

• Muscle Hypertrophy & Repair: It directly aids in muscle tissue growth and speeds up recovery following strenuous physical exertion.

• Metabolic & Joint Support: Promotes efficient fat oxidation and stimulates collagen synthesis, benefiting joint, bone, and skin health.

• Improved Sleep & Energy: Researchers frequently note deeper sleep cycles and a significant boost in overall vitality.

Recommended Administration & Protocols

Because of its long-lasting nature, CJC-1295 with DAC requires much less frequent dosing than standard GHRH analogues.

• Injection Frequency: Optimal results are typically achieved with 1–2 injections per week (twice-weekly dosing is standard).

• Reconstitution: Each box contains one 2mg vial and sterile water for proper preparation.

• Weekly Dosage:

  • Standard Range: Clinical data suggests 15–30 mcg per kg of body weight weekly.

  • Performance Range: In athletic contexts, doses of 2000–5000 mcg per week are common for muscle development.

• Synergistic Stacking: For maximum GH pulse intensity, it is often combined with a Growth Hormone Releasing Peptide (GHRP) like Ipamorelin.

Safety and Handling Guidelines

CJC-1295 with DAC is a potent research compound that must be used responsibly. To ensure safety and maintain the integrity of the peptide, users should follow precise reconstitution protocols and consult with a qualified healthcare professional before initiating a cycle.